Healthcare
|
Health Care
|
|
|
|
Your feedback matters to us.
|
|
|
|
Trump's proposed research rule faces pushback |
Patient groups, scientists, bipartisan lawmakers, pharmaceutical companies and more are all sounding alarms over a Trump administration proposal they say would politicize scientific grant funding and undermine America’s biomedical research leadership at a critical time.
|
© AP Photo/Gary M. Baranec
|
The proposed rule from the White House Office of Management and Budget has received almost 342,000 comments, which were due Monday. The agency says it intends to finalize the rule in time for it to take effect Oct. 1.
According to one analysis, an overwhelming majority of the comments oppose the changes. The proposed rule would codify many policies the administration attempted through executive order and at the individual agency level.
All discretionary awards from the federal government would have to be reviewed by senior administration officials, who could deny them because they didn’t fit the president’s agenda. Existing awards could be cancelled at any time for no apparent reason, with little recourse.
The rule would ban research on diversity, equity and inclusion in addition to gender as grant conditions and would place a broad prohibition on international scientific collaborations. It would also restrict international collaboration at a time when China’s rapid rise is threatening America’s status as the world leader in biomedical research.
The White House has characterized the proposed rule as necessary to improve transparency and cut down waste, fraud and abuse across all of government.
On Monday, 57 leading patient advocacy organizations representing millions of Americans living with chronic and acute diseases called on congressional leaders to push OMB to withdraw the rule before it takes effect. The organizations are part of a collaborative network called United for Cures.
“We have grave concerns,” the groups wrote, arguing it would “further cede the role of global scientific leader to other countries, including China.”
Additionally, the rule “would leave patients participating in clinical trials without further treatment, potentially wasting millions of dollars in federal funding and taking hope away from individuals who are benefitting from cutting-edge treatments.”
|
Welcome to The Hill’s Healthcare newsletter, we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.
|
|
|
|
How policy will be impacting the healthcare sector this week and beyond:
|
|
|
|
The federal watchdog for the Department of Health and Human Services generated $5.56 billion in expected recoveries and projected savings over a six-month period, according to a report issued Monday, and barred just over 1,200 individuals and companies from federal programs. The HHS Office of Inspector General, in a semiannual report to Congress, said it returned $12.70 for every dollar it spent between October 2025 through …
|
|
|
|
|
Sen. Lindsey Graham’s (R-S.C.) sudden death on Saturday at the age of 71 has been attributed to an aortic dissection, raising questions over the rare but often fatal condition. Francisco Diaz, D.C.’s chief medical examiner, said in a statement Sunday that his office’s preliminary findings indicate that “aortic dissection due to arteriosclerosis cardiovascular disease” was the cause of Graham’s death. Aortic …
|
|
|
|
|
A second U.S. citizen was diagnosed with Ebola on Friday and subsequently transferred to Germany for treatment, according to the World Health Organization (WHO). The individual, whose identity was not revealed, is a humanitarian worker and was admitted to Frankfurt University Hospital early on Monday. “As infections among response personnel are not unexpected in an outbreak of this scale, protecting frontline responders …
|
|
|
|
|
Upcoming news themes and events we’re watching:
|
- The Senate HELP Committee holds a confirmation hearing Wednesday for two key nominees: CDC director and the HHS Assistant Secretary for Preparedness and Response
|
|
|
|
Branch out with a different read:
|
|
|
|
States sue over planned cuts to school mental health grants
|
A group of more than a dozen state attorneys general is suing the Department of Education (DOE) for what they claim to be the unlawful termination of congressionally approved mental health grants for public school students. The lawsuit filed on Friday was done so “protectively” essentially to back up a prior lawsuit filed by states in which a federal judge issued an injunction on a plan by the department to terminate …
|
|
|
|
Local and state headlines on healthcare:
|
- As GOP cries fraud, Newsom backs Medicaid spending on housing and food (KFF Health News)
- Eight school-based health clinics close in Southwest Virginia as federal funding pressures mount (Virginia Mercury)
- Missouri governor signs wide-ranging bipartisan healthcare bill into law (Missouri Independent)
|
|
|
|
Health news we’ve flagged from other outlets:
|
- Trump's HHS abandons threat to withhold Medicare and Medicaid funding over trans care (NPR)
- Bayer seeks to end federal Roundup litigation after Supreme Court win (Reuters)
- As states absorb Medicaid funding cuts, family caregivers face financial ruin (Stat)
|
|
|
|
Opinions related to health submitted to The Hill:
|
|
|
|
|
You’re all caught up. See you tomorrow!
|
400 N Capitol Street NW Suite 650, Washington, DC 20001
|
Copyright © 1998 - 2026 Nexstar Media Inc. | All Rights Reserved.
|
|
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment